Nutritional factors in the prevention and management of coronary artery disease and heart failure

被引:28
|
作者
Das, Undurti N. [1 ,2 ,3 ]
机构
[1] UND Life Sci, Federal Way, WA USA
[2] Gayatri Vidya Parishad Hosp, Dept Med, Visakhapatnam, Andhra Pradesh, India
[3] Gayatri Vidya Parishad Hosp, BioSci Res Ctr, Visakhapatnam, Andhra Pradesh, India
关键词
Nutrients; Polyunsaturated fatty acids; Vitamins; Pyridoxine; Lipoxins; Resolvins; Protectins; Heart failure; Atherosclerosis; Coronary artery disease; Nitric oxide; Asymmetrical dimethylarginine; Magnesium; Eicosanoids; Arrhythmias; Cytokines; L-arginine; POLYUNSATURATED-FATTY-ACIDS; ENDOTHELIUM-DEPENDENT VASODILATION; LONG-CHAIN OMEGA-3-FATTY-ACIDS; METABOLIC SYNDROME-X; C-REACTIVE PROTEIN; ASYMMETRIC DIMETHYLARGININE; MAGNESIUM-DEFICIENCY; PLASMA HOMOCYSTEINE; DIABETES-MELLITUS; ARACHIDONIC-ACID;
D O I
10.1016/j.nut.2014.08.011
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Nutritional factors such as magnesium, folic acid, vitamins B-12 and B-6, L-arginine, and polyunsaturated fatty acids (PUFAs) appear to be significantly beneficial for patients with coronary artery disease (CAD), and in the prevention and arresting the progression of HF and cardiac arrhythmias. Additionally, ingestion of adequate amounts of protein and maintaining normal concentrations of plasma albumin seem to be essential for these patients. These nutrients closely interact with the metabolism of L-arginine-nitric oxide (NO) system, essential fatty acids, and eicosanoids such that beneficial products such as NO, prostaglandin E-1, prostacyclin, prostaglandin I-3, lipoxins, resolvins, and protectins are generated and synthesis of proinflammatory cytokines is suppressed that results in platelet anti-aggregation, vasodilation, angiogenesis, and prevention of CAD, cardiac arrhythmias, and stabilization of HF. This implies that individuals at high risk for CAD, cardiac arrhythmias, and HF and those who have these diseases need to be screened for plasma levels of magnesium, folic acid, vitamins B-12 and B-6, L-arginine, NO, various PUFAs, lipoxin A(4), resolvins, protectins, asymmetrical dimethylarginine (an endogenous inhibitor of NO), albumin, and various eicosanoids and cytokines and correct their abnormalities to restore normal physiology. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条
  • [21] HEART FAILURE RISK FACTORS ANALYSIS ON STABLE CORONARY ARTERY DISEASE PATIENTS IN CHINA
    Chen, J.
    Wudong, G.
    Li, X.
    Wang, Y.
    [J]. VALUE IN HEALTH, 2020, 23 : S107 - S107
  • [22] Asymptomatic Coronary Artery Disease in Chagasic Patients with Heart Failure: Prevalence and Risk Factors
    Carvalho, Gustavo
    Rassi, Salvador
    Dias de Azeredo Bastos, Jose Maria
    Pontes Camara, Silvio Sergio
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (05) : 408 - 412
  • [23] Prevention of Coronary Artery Disease-Related Heart Failure: The Role of Computed Tomography Scan
    Fusaro, Michele
    Tessarin, Giovanni
    [J]. HEART FAILURE CLINICS, 2021, 17 (02) : 187 - 194
  • [24] Ivabradine in the treatment of heart failure and coronary artery disease
    Verschuren, J. J. W.
    Jukema, J. W.
    [J]. NETHERLANDS HEART JOURNAL, 2011, 19 : 20 - 22
  • [25] Navigating the crossroads of coronary artery disease and heart failure
    Gheorghiade, Mihai
    Sopko, George
    De Luca, Leonardo
    Velazquez, Eric J.
    Parker, John D.
    Binkley, Philip F.
    Sadowski, Zygmunt
    Golba, Krzysztof S.
    Prior, David L.
    Rouleau, Jean L.
    Bonow, Robert O.
    [J]. CIRCULATION, 2006, 114 (11) : 1202 - 1213
  • [26] Left heart failure and coronary artery disease in COPD
    Beauvais, F
    Logeart, D
    Tartière, JM
    Bouvier, E
    Cohen-Solal, A
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2003, 20 (06) : S39 - S44
  • [27] Sexuality in patients with coronary artery disease and heart failure
    Bernardo, A
    [J]. HERZ, 2001, 26 (05) : 353 - 359
  • [28] Heart failure therapy in patients with coronary artery disease
    Taylor, Clare J.
    Hobbs, F. D. Richard
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) : 205 - 209
  • [29] Heart Failure With Obstructive, Nonobstructive, and No Coronary Artery Disease
    Shaw, Leslee J.
    Arbustini, Eloisa
    Narula, Jagat
    [J]. JACC-HEART FAILURE, 2019, 7 (06) : 502 - 504
  • [30] Ivabradine in the management of coronary artery disease with or without left ventricular dysfunction or heart failure
    Ferrari, Roberto
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0G) : G24 - G29